Brief: Corvus Pharmaceuticals Q3 EPS USD -0.12
04/11/2025 21:01
Nov 04 (Reuters) - Corvus Pharmaceuticals Q3 basic EPS USD -0.12. Q3 operating income USD -10.572 million Q3 net income USD -10.157 million Q3 operating expenses USD 10.572 million
Recent news on Corvus Pharmaceuticals
See all newsBrief: Corvus Pharmaceuticals Announces Initiation Of Phase 1B Clinical Trial Of Soquelitinib For Patients With Hidradenitis Suppurativa
Corvus Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
U.S. STOCKS ON THE MOVE-Cleveland-Cliffs, Ciena Corp, Nokia Oyj
U.S. STOCKS ON THE MOVE-Cleveland-Cliffs, Ciena Corp, Nokia Oyj
U.S. STOCKS ON THE MOVE-Toll Brothers, TG Therapeutics, CECO Environmental